Klaus Elenius

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab

Minna Tanner, Maija Hollmén, Teemu T. Junttila et al. · Annals of Oncology · 2005 · 656 citations

Intestinal Type, Oncology, Gastrointestinal Oncology +11

Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation

Klaus Elenius · The EMBO Journal · 1997 · 348 citations · Full text

Developmental Biology, Cell Proliferation, Cell Growth +5

High frequency of <scp>BRAF</scp><scp>V600E</scp> mutations in ameloblastoma

Kari J. Kurppa, Javier Catón, Peter R. Morgan et al. · The Journal of Pathology · 2013 · 296 citations · Full text

Mutant Braf, Erbb Receptors, Medicine +13

Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer

Minna Tanner, Anita I. Kapanen, Teemu T. Junttila et al. · Molecular Cancer Therapeutics · 2004 · 267 citations · Full text

Tumor Biology, Breast Oncology, Novel Cell Line +13

Signaling via ErbB2 and ErbB3 Associates with Resistance and <i>Epidermal Growth Factor Receptor</i> (<i>EGFR</i>) Amplification with Sensitivity to EGFR Inhibitor Gefitinib in Head and Neck Squamous Cell Carcinoma Cells

Kaisa Erjala, Maria Sundvall, Teemu T. Junttila et al. · Clinical Cancer Research · 2006 · 255 citations · Full text